当前位置:首页 - 行情中心 - 诺泰生物(688076) - 财务分析

诺泰生物

(688076)

  

流通市值:82.01亿  总市值:119.45亿
流通股本:1.46亿   总股本:2.13亿

诺泰生物(688076)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.65亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益226835.42万元,未分配利润53093.50万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产371926.07万元,负债145090.65万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入355,815,137.721,033,548,079.03709,466,382.95400,781,544.83
营业总成本268,734,197.03827,280,234.64576,242,770.64338,329,296.68
营业利润80,820,160.49189,665,794.91121,070,282.0454,164,718.88
利润总额80,450,710.62173,126,873.98114,846,980.2247,875,645.05
净利润64,564,924.95165,452,661.9690,339,373.1139,851,244.79
其他综合收益--24,617,700--
综合收益总额64,564,924.95140,834,961.9690,339,373.1139,851,244.79
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,548,243,894.591,494,767,183.421,039,565,285.34980,874,514.03
非流动资产合计2,171,016,787.272,052,478,769.021,873,655,329.631,636,426,386.82
资产总计3,719,260,681.863,547,245,952.442,913,220,614.972,617,300,900.85
流动负债合计1,063,598,128.82973,335,211.93870,731,195.94643,420,491.81
非流动负债合计387,308,372.14384,607,065.7656,951,335.4950,686,518.03
负债合计1,450,906,500.961,357,942,277.69927,682,531.43694,107,009.84
归属于母公司股东权益合计2,250,061,830.382,170,268,338.071,971,192,291.521,910,011,308.58
股东权益合计2,268,354,180.92,189,303,674.751,985,538,083.541,923,193,891.01
负债和股东权益合计3,719,260,681.863,547,245,952.442,913,220,614.972,617,300,900.85
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计363,931,590.821,128,307,892.48746,154,754.78495,212,997.86
经营活动现金流出小计285,447,328.3778,094,074.53510,989,307.42322,438,523.59
经营活动产生的现金流量净额78,484,262.52350,213,817.95235,165,447.36172,774,474.27
投资活动现金流入小计260,262,153.82554,930,317.79466,834,956.94346,236,031.25
投资活动现金流出小计667,227,750.521,217,139,130.78945,518,903.02562,536,757.63
投资活动产生的现金流量净额-406,965,596.7-662,208,812.99-478,683,946.08-216,300,726.38
筹资活动现金流入小计260,000,0001,145,777,196.4607,795,759.55470,000,000
筹资活动现金流出小计111,518,848.52513,881,214.47494,815,359.24415,560,894.32
筹资活动产生的现金流量净额148,481,151.48631,895,981.93112,980,400.3154,439,105.68
汇率变动对现金及现金等价物的影响986,035.2-3,213,148.59-1,543,074.98-689,556.16
现金及现金等价物净增加额-179,014,147.5316,687,838.3-132,081,173.3910,223,297.41
期末现金及现金等价物余额498,518,585.31677,532,732.81228,763,721.12371,068,191.92
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋,胡偌碧1.041.441.962024-04-25
民生证券王班1.081.552.202024-04-23
中泰证券崔少煜,祝嘉琦1.041.462.112024-04-22
浙商证券孙建,郭双喜1.091.572.272024-04-11
中泰证券崔少煜,祝嘉琦1.041.462.112024-04-07
TOP↑